Snezana is a myeloma patient the president of the Serbian Association of Myeloma Patients (Udruženje obolelih od multiplog mijeloma Srbije). She spent years working as a business consultant covering finance, regulatory frameworks, international trade and distribution and also served as finance director with extensive experience at board level. Snezana’s mission is sharing knowledge, experiences, advocacy strategies, and developing collaboration between different EU regions to improve the capacities of CEE country myeloma associations.
EMA committee recommends teclistamab plus daratumumab for relapsed or refractory multiple myeloma
On 25 June 2026, the Committee for Medicinal Products for Human Use (CHMP) recommended extending the approved use of teclistamab (Tecvayli®) to include its use in combination with daratumumab for…